Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Quintiliani

Showing results (201-210 of 276) with videos related to

Pageof 28
Sort By:
American Journal of Surgery|May 31, 1988
The conversion of cefoxitin usage to cefotetan: an interdisciplinary approachC H Nightingale, K S Smith, R Quintiliani, et al.
Hospital Pharmacy|August 1, 1995
Implementation of a once-daily aminoglycoside program in a large community-teaching hospitalD P Nicolau, P P Belliveau, C H Nightingale, et al.
The Journal of Bone and Joint Surgery. American Volume|October 1, 1977
The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacementB A Cunha, H R Gossling, H S Pasternak, et al.
Pharmacotherapy|July 1, 1997
Pharmacoeconomic impact of once-daily aminoglycoside administrationC M Hitt, M E Klepser, C H Nightingale, et al.
Current Therapeutic Research, Clinical and Experimental|January 1, 1976
Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluidH P Bassaris, R Quintiliani, E G Maderazo, et al.
Archives of Internal Medicine|January 1, 1982
Meningovascular syphilis after 'appropriate' treatment of primary syphilisB L Moskovitz, J J Klimek, R L Goldman, et al.
The Journal of Antimicrobial Chemotherapy|December 10, 1999
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis modelM K Lacy, D P Nicolau, M A Banevicius, et al.
International Journal of Antimicrobial Agents|June 17, 2000
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococciM K Lacy, P R Tessier, D P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureusD P Nicolau, C D Freeman, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgeryM N Dudley, C H Nightingale, A D Drezner, et al.
Pageof 28

Showing results (201-210 of 276) with videos related to

Sort By:
Pageof 28
American Journal of Surgery|May 31, 1988
The conversion of cefoxitin usage to cefotetan: an interdisciplinary approachC H Nightingale, K S Smith, R Quintiliani, et al.
Hospital Pharmacy|August 1, 1995
Implementation of a once-daily aminoglycoside program in a large community-teaching hospitalD P Nicolau, P P Belliveau, C H Nightingale, et al.
The Journal of Bone and Joint Surgery. American Volume|October 1, 1977
The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacementB A Cunha, H R Gossling, H S Pasternak, et al.
Pharmacotherapy|July 1, 1997
Pharmacoeconomic impact of once-daily aminoglycoside administrationC M Hitt, M E Klepser, C H Nightingale, et al.
Current Therapeutic Research, Clinical and Experimental|January 1, 1976
Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluidH P Bassaris, R Quintiliani, E G Maderazo, et al.
Archives of Internal Medicine|January 1, 1982
Meningovascular syphilis after 'appropriate' treatment of primary syphilisB L Moskovitz, J J Klimek, R L Goldman, et al.
The Journal of Antimicrobial Chemotherapy|December 10, 1999
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis modelM K Lacy, D P Nicolau, M A Banevicius, et al.
International Journal of Antimicrobial Agents|June 17, 2000
Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococciM K Lacy, P R Tessier, D P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureusD P Nicolau, C D Freeman, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgeryM N Dudley, C H Nightingale, A D Drezner, et al.
Pageof 28